STERICYCLE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.18 USD | +3.08% |
|
-0.28% | -6.82% |
| Apr. 26 | Truist Securities Cuts Stericycle's Price Target to $50 From $57, Hold Rating Maintained | MT |
| Apr. 25 | Transcript : Stericycle, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.05 times its estimated earnings per share for the ongoing year.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Environmental Services & Equipment
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -6.82% | 4.28B | B | ||
| +9.99% | 42.36B | C+ | ||
| -1.90% | 12.34B | C+ | ||
| +7.21% | 5.32B | C+ | ||
| +0.37% | 3.98B | B- | ||
| -1.76% | 2.39B | C+ | ||
| +6.23% | 2.07B | - | ||
| -5.26% | 1.54B | - | ||
| +3.34% | 1.44B | C- | ||
| -8.80% | 1.36B | C+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SRCL Stock
- Ratings Stericycle, Inc.
